Earnings summaries and quarterly performance for SHINECO.
Research analysts covering SHINECO.
Recent press releases and 8-K filings for SISI.
Shineco Subsidiary Secures Technology Contract and Forms International Alliance
SISI
New Projects/Investments
Revenue Acceleration/Inflection
- Shineco's subsidiary, Xi'an Dong'ao Health Management Co., Ltd. ("Dong'ao Health"), has signed an $8.7 million technology services contract with Xinke Future Biotechnology (Bazhou) Co., Ltd. for the research and development of "microalgae-derived extracellular vesicles" technology.
- The service period for this contract runs from August 25, 2025, to December 31, 2026, with an initial payment of $560,000 already received, providing near-term financial momentum for Shineco.
- Separately, Dong'ao Health reached a broad consensus on key collaboration areas, including establishing a joint laboratory and a technology exchange mechanism, with Singapore's BICC, a biotechnology company with an extensive commercial network of over 3,000 agents across Southeast Asia.
Sep 12, 2025, 1:30 PM
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more